Pharmaceutical

Ligand Pharmaceuticals to acquire APEIRON Biologics for $100m

Ligand Pharmaceuticals has announced a definitive agreement for the acquisition of APEIRON Biologics in a deal worth $100m in cash.

Jul 10, 2024 - 04:00
Ligand Pharmaceuticals to acquire APEIRON Biologics for $100m
Ligand Pharmaceuticals has announced a definitive agreement for the acquisition of APEIRON Biologics in a deal worth $100m in cash.
Read the original article

Tags:

Previous Article

Taiho exercises option for Arcus Biosciences’ quemliclustat in Asia

Next Article

Moderna and Mitsubishi Tanabe link on mRNA vaccines in Japan

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: EU regulator recommends expanding diabetes drug Mounjaro’s approval to include obesity

STAT+: EU regulator recommends expanding diabetes drug ...

Nov 11, 2023

STAT+: Medicare is urged to monitor how rebates affect Part D drug spending, but agency demurs

STAT+: Medicare is urged to monitor how rebates affect ...

Sep 14, 2023

FDA updates stimulant labelling requirements to reduce misuse

FDA updates stimulant labelling requirements to reduce ...

May 12, 2023